Unlocking New Possibilities in Ulnar Collateral Ligament (UCL) Repair: The benefits of SF Push-in Anchor 2.3 for Thumb Stability

 

The SF Push-in Anchor 2.3 with SupraFusion® Technology addresses challenges in ulnar collateral ligament repair through cancellous bone fixation, offering a unique solution with high patient satisfaction and functional recovery.

Ulnar collateral ligament (UCL) injuries can lead to thumb instability, reduced grip and pinch strength, and limited range of motion. UCL repair at the thumb metacarpophalangeal (MCP) joint is particularly challenging in cases involving fragmentary or small avulsions. Traditional fixation techniques may fail due to reliance on cortical bone, especially in compromised bone quality or anatomy.

In this prospective clinical study, Kastenberger et al [1] evaluated 24 patients who underwent UCL repair at the MCP joint using the bioabsorbable SF Push-in Anchor 2.3, fixed at the bone interface with SupraFusion® Technology (Figure 1). Postoperatively follow-ups were conducted at 12 and 52 weeks [1].

At 52 weeks, pain was minimal, with low mean VAS scores at rest (0.2 ± 0.7) and during load (0.6 ± 1.0) (Figure 2a). DASH disability scores improved significantly (Figure 2a), while 81% of patients reported being "very satisfied” (Figure 2b ).

Results obtained can be attributed to the innovative design of SF Push-in Anchor 2.3, which achieves secure fixation by infiltrating porous cancellous bone. This maximizes the bone-implant interface along the implant’s length, enhancing stability while addressing challenges such as fragmentary avulsions. SF Push-in Anchor 2.3 with SupraFusion® Technology provides a unique and effective fixation strategy for advanced scenarios, providing smaller and resorbable implants with high pull-out strength thereby expanding treatment possibilities for challenging UCL injuries.

 
 

References

[1] T. Kastenberger, P. Kaiser, G. Schmidle, K. Stock, S. Benedikt, and R. Arora, ‘Clinical results of the BoneWelding®Fiji® anchor for the treatment of Stener lesions of the thumb’, Arch Orthop Trauma Surg, vol. 141, no. 9, pp. 1499–1507, Sep. 2021, doi: 10.1007/s00402-020-03625-x.

 
 
 

Figure 1. Schematic view of the implantation of the SF Push-in Anchor 2.3.

 

Figure 2. Pain, Dash Scores (a) and patient satisfaction (b) 52 weeks postsurgery

Dr. Marina Rubert

Meet Dr. Marina, a trailblazer in the realm of biomedical sciences whose journey spans across Europe's prestigious institutions. A dual graduate in Biology and Biochemistry from the University of Balearic Islands in 2006, Marina's early career saw her delving into biomaterials at the University of Oslo, collaborating with Numat AS. Her quest for innovation led her to a PhD focused on breakthroughs in bone regeneration and biomaterials, culminating in 2013. Marina's expertise deepened through her postdoctoral fellowship at Aarhus University's ELECTROMED group, and in 2014, she furthered her research at ETH Zurich's Laboratory for Bone Biomechanics with a Marie Curie scholarship.

Specializing in cell and molecular biology, 3D tissue engineering, and biomaterials development, Marina has pioneered methods to enhance tissue regeneration and reduce inflammation from material implants. Since 2018, she has also taken on roles as Biosafety officer and Laboratory Manager, ascending to Senior Scientist in 2019 and leading the 'Personalized Tissue Engineering and Regenerative Medicine' team.

With 30 peer-reviewed publications (and counting) under her belt, Marina's contributions to the field are monumental. As a seasoned lecturer and mentor, she has guided numerous students and postdocs towards their own scientific discoveries. A respected member of editorial and scientific committees, her expertise enriches the fields of biomaterials and bioengineering. Dr. Marina continues to push the boundaries of medical science, making significant strides towards the future of regenerative medicine.

Previous
Previous

The Advantages of PLDLLA Bioresorbable Implants to treat Sports Medicine injuries

Next
Next

SupraFusion - Implant Stability in Osteopenic Bone